Suppr超能文献

血清细胞因子和趋化因子谱与中国 2019 年冠状病毒病严重程度的关系。

Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.

机构信息

NHC Key laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.

Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.

出版信息

J Infect Dis. 2020 Aug 4;222(5):746-754. doi: 10.1093/infdis/jiaa363.

Abstract

Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We investigated the serum cytokine and chemokine levels in asymptomatic, mild, moderate, severe, and convalescent SARS-CoV-2-infected cases. Proinflammatory cytokine and chemokine production induced by SARS-CoV-2 were observed not only in symptomatic patients but also in asymptomatic cases, and returned to normal after recovery. IL-6, IL-7, IL-10, IL-18, G-CSF, M-CSF, MCP-1, MCP-3, IP-10, MIG, and MIP-1α were found to be associated with the severity of COVID-19. Moreover, a set of cytokine and chemokine profiles were significantly higher in SARS-CoV-2-infected male than female patients. The serum levels of MCP-1, G-CSF, and VEGF were weakly and positively correlated with viral titers. We suggest that combinatorial analysis of serum cytokines and chemokines with clinical classification may contribute to evaluation of the severity of COVID-19 and optimize the therapeutic strategies.

摘要

2019 年冠状病毒病(COVID-19)是由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的新发传染病。我们研究了无症状、轻症、中度、重症和康复 SARS-CoV-2 感染病例的血清细胞因子和趋化因子水平。SARS-CoV-2 诱导的促炎细胞因子和趋化因子的产生不仅在有症状的患者中观察到,而且在无症状病例中也观察到,并且在恢复后恢复正常。IL-6、IL-7、IL-10、IL-18、G-CSF、M-CSF、MCP-1、MCP-3、IP-10、MIG 和 MIP-1α 与 COVID-19 的严重程度相关。此外,一组细胞因子和趋化因子谱在 SARS-CoV-2 感染的男性患者中明显高于女性患者。MCP-1、G-CSF 和 VEGF 的血清水平与病毒滴度呈弱正相关。我们建议,将血清细胞因子和趋化因子与临床分类相结合进行综合分析,可能有助于评估 COVID-19 的严重程度并优化治疗策略。

相似文献

1
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
J Infect Dis. 2020 Aug 4;222(5):746-754. doi: 10.1093/infdis/jiaa363.
2
Clinical and pathological investigation of patients with severe COVID-19.
JCI Insight. 2020 Jun 18;5(12):138070. doi: 10.1172/jci.insight.138070.
3
IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
Mol Med. 2020 Oct 29;26(1):97. doi: 10.1186/s10020-020-00230-x.
5
Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients.
Aging (Albany NY). 2020 Jun 1;12(11):10059-10069. doi: 10.18632/aging.103255.
6
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Neuroscientist. 2020 Oct-Dec;26(5-6):402-414. doi: 10.1177/1073858420941476. Epub 2020 Jul 18.
9
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.
Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18.

引用本文的文献

1
Evaluation of vitamin D status, vitamin D receptor expression, and innate immune mediators in COVID-19.
Front Endocrinol (Lausanne). 2025 Aug 19;16:1600623. doi: 10.3389/fendo.2025.1600623. eCollection 2025.
4
A comparative analysis of estrogen receptors, ACE2 and cytokines in pre-and postmenopausal women and men with COVID-19.
Front Public Health. 2025 Apr 28;13:1554024. doi: 10.3389/fpubh.2025.1554024. eCollection 2025.
6
Eosinophils and COVID-19: Insights into immune complexity and vaccine safety.
Clin Transl Allergy. 2025 Mar;15(3):e70050. doi: 10.1002/clt2.70050.
7
MIP-3-Alpha and MIP-3-Beta as Early Predictors of Pneumonia in Polytraumatized Patients.
Lung. 2025 Mar 13;203(1):44. doi: 10.1007/s00408-025-00799-2.
10
Cxcl10 is required for survival during SARS-CoV-2 infection in mice.
bioRxiv. 2024 Oct 1:2024.09.30.613319. doi: 10.1101/2024.09.30.613319.

本文引用的文献

1
Asymptomatic SARS-CoV-2 infected patients with persistent negative CT findings.
Eur J Radiol. 2020 May;126:108956. doi: 10.1016/j.ejrad.2020.108956. Epub 2020 Mar 12.
2
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
3
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.
5
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.
N Engl J Med. 2020 Mar 19;382(12):1177-1179. doi: 10.1056/NEJMc2001737. Epub 2020 Feb 19.
7
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.
8
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
A Novel Coronavirus from Patients with Pneumonia in China, 2019.
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验